Panacea Biotec completes share buy-back
Drug maker Panacea Biotec on Monday said it has closed its share buy-back offer with an outgo of Rs 109.82 crore.
By PTI |
NEW DELHI: Drug maker Panacea Biotec on Monday said it has closed its share buy-back offer with an outgo of Rs 109.82 crore.
The company has bought back 5,592,000 equity shares for an aggregate consideration of Rs 109.82 crore, Panacea Biotec said in a filing to Bombay Stock Exchange ( BSE).
The offer began on July 12 this year with the company announcing that it will buy back 24.94 per cent stake in firm from public shareholders for up to Rs 128.05 crore.
Under the offer, the company had proposed to purchase a minimum of 10 lakh and a maximum of 55.92 lakh shares of face value of Re 1 each.
Shares of Panacea Biotec on Monday closed at Rs 201 on BSE up 0.45 per cent from its previous close.
The company has bought back 5,592,000 equity shares for an aggregate consideration of Rs 109.82 crore, Panacea Biotec said in a filing to Bombay Stock Exchange ( BSE).
The offer began on July 12 this year with the company announcing that it will buy back 24.94 per cent stake in firm from public shareholders for up to Rs 128.05 crore.
Under the offer, the company had proposed to purchase a minimum of 10 lakh and a maximum of 55.92 lakh shares of face value of Re 1 each.
Shares of Panacea Biotec on Monday closed at Rs 201 on BSE up 0.45 per cent from its previous close.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
'Shared ambition of reliable, open, safe AI': Macron at Bharat Innovates seeks ethical use of AI2026-06-14T12:26:00Z- Love instant popcorns, diet drinks? Celebrity nutritionist shares 5 common foods that may be quietly ruining your health2026-06-14T09:19:02Z
- ‘Civic sense, zero potholes, less honking, functional street lights’: Indian traveller in Bangkok shares simple things that Indian cities lack2026-06-14T08:48:17Z
ADVERTISEMENT
